Mortality among multidrug-resistant tuberculosis patients participating in the delamanid clinical development programme
| Patients | Mortality | OR (95% CI) | |
| 2-month sputum culture conversion | |||
| Yes | 192 | 6 (3.1) | 0.25 (0.10–0.61)# |
| No | 272 | 31 (11.4) | 1.00 |
| Delamanid treatment duration | |||
| ≥6 months | 205 | 6 (2.9) | 0.22 (0.09–0.54)¶ |
| ≤2 months | 259 | 31 (12.0) | 1.00 |
| Total | 464 | 37 |
Data are presented as n or n (%), unless otherwise stated. #: p=0.002; ¶: p=0.001.